Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

87.60
+0.13500.15%
Volume:22.33K
Turnover:1.96M
Market Cap:6.75B
PE:77.52
High:88.29
Open:87.68
Low:87.35
Close:87.46
52wk High:91.69
52wk Low:43.75
Shares:77.09M
Float Shares:28.15M
Volume Ratio:0.50
T/O Rate:0.08%
Dividend:0.46
Dividend Rate:0.53%
EPS(TTM):1.13
EPS(LYR):0.9358
ROE:11.52%
ROA:7.07%
PB:18.99
PE(LYR):93.60

Loading ...

Data-Center Backlash Leads to a New Land Rush in the Texas Oil Patch

Dow Jones
·
Aug 10

Stock Track | LandBridge Soars 5.71% After-Hours on Q2 Earnings Beat and Strong Revenue Growth

Stock Track
·
Aug 06

LandBridge Q2 Net Income Rises 68% Year-over-Year to $31 Million; Revenue Increases 41% Year-over-Year to $66.8 Million

Reuters
·
Aug 06

LandBridge Q2 Revenue Rises 41%, Beats Expectations

Reuters
·
Aug 06

LandBridge Q2 Sales $66.840M Beat $60.117M Estimate

Benzinga Earnings
·
Aug 06

LandBridge Co LLC Q2 Free Cash Flow USD 40.2 Million

Reuters
·
Aug 06

Landbridge Co Llc Q2 Free Cash Flow USD 40.2 Million

THOMSON REUTERS
·
Aug 06

Landbridge Co Llc Q2 Net Income USD 31 Million

THOMSON REUTERS
·
Aug 06

Landbridge Co Llc Q2 Adjusted Ebitda Margin 89%

THOMSON REUTERS
·
Aug 06

Press Release: LandBridge Announces Second Quarter 2026 Results

Dow Jones
·
Aug 06

LandBridge Co LLC Expected to Post Earnings of 44 Cents a Share - Earnings Preview

Reuters
·
Aug 04

LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 03

Earning Preview: LandBridge Co. LLC revenue is expected to increase by 23.39%, and institutional views are optimistic

Earnings Agent
·
Jul 29

LandBridge and WaterBridge Stocks are Setting up for Gains

Dow Jones
·
Jul 28

LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained

TIPRANKS
·
Jul 23

Landbridge is Maintained at Neutral by Piper Sandler

Dow Jones
·
Jul 22

LB Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Jul 21

Landbridge Schedules Second-quarter Earnings Release, Conference Call

Reuters
·
Jul 14

Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Jul 11

LB Pharmaceuticals Initiated at Outperform by Wolfe Research

Dow Jones
·
Jul 07